Nasopharyngeal Myiasis in Intensive Care Unit (ICU) Patients: Report of Two Cases

Hosna  Zobairy; Parisa  Modaresi; Miguel M  Cabada; Ahmad  Sofi-Mahmudi

doi:10.18502/ijpa.v18i1.12388

Hosna Zobairy Department of Otolaryngology, Kurdistan University of Medical Sciences, Sanandaj, Iran
Parisa Modaresi Department of Pathology, Kurdistan University of Medical Sciences, Sanandaj, Iran
Miguel M Cabada Division of Infectious Diseases, University of Texas Medical Branch. Galveston, Texas
Ahmad Sofi-Mahmudi Cochrane Iran Associate Centre, National Institute for Medical Research Development (NIMAD), Tehran, Iran

DOI: https://doi.org/10.18502/ijpa.v18i1.12388

Keywords: Nosocomial myiasis; Nasopharyngeal; COVID-19; Lucilia sericata

Abstract

Nosocomial myiasis is a rare event that has a higher incidence in the hospitals of poor and developing countries. The presence of nosocomial myiasis reflects the need for improved medical facilities and increased awareness among healthcare personnel. Severely ill patients are more susceptible, such as those with impaired consciousness, paralysis, and underlying diseases. The two cases here in described represent the first report of nosocomial myiasis in the Kurdistan Province, in Western Iran and one of them is the first report of myiasis involving a COVID-19-infected patient. The causal agent was Lucilia sericata. The taxonomical identification of the larvae of the second and third instar was based on the morphology of the cephaloskeleton, anterior spiracles, and peritreme plaques.